Capricor Therapeutics ROA 2006-2020 | CAPR

Current and historical return on assets (ROA) values for Capricor Therapeutics (CAPR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Capricor Therapeutics ROA for the three months ending March 31, 2020 was -70.97%.
Capricor Therapeutics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-03-31 $-0.01B $0.01B -70.00%
2019-12-31 $-0.01B $0.01B -91.43%
2019-09-30 $-0.01B $0.01B -121.21%
2019-06-30 $-0.01B $0.01B -129.73%
2019-03-31 $-0.01B $0.01B -127.27%
2018-12-31 $-0.02B $0.01B -120.00%
2018-09-30 $0.00B $0.01B 0.00%
2018-06-30 $0.00B $0.01B 6.56%
2018-03-31 $0.00B $0.02B 13.11%
2017-12-31 $0.00B $0.02B 13.33%
2017-09-30 $-0.02B $0.02B -95.24%
2017-06-30 $-0.02B $0.01B -95.77%
2017-03-31 $-0.02B $0.01B -107.04%
2016-12-31 $-0.02B $0.02B -102.70%
2016-09-30 $-0.02B $0.02B -95.77%
2016-06-30 $-0.02B $0.01B -89.55%
2016-03-31 $-0.01B $0.02B -67.53%
2015-12-31 $-0.01B $0.02B -55.17%
2015-09-30 $-0.01B $0.02B -51.76%
2015-06-30 $-0.01B $0.02B -49.38%
2015-03-31 $-0.01B $0.03B -48.00%
2014-12-31 $-0.01B $0.01B -43.75%
2014-09-30 $-0.01B $0.02B -64.29%
2014-06-30 $-0.01B $0.02B -90.00%
2014-03-31 $-0.01B $0.02B -163.64%
2013-12-31 $-0.01B $0.01B -600.00%
2013-09-30 $-0.01B $0.00B -400.00%
2013-06-30 $-0.00B $0.00B -320.00%
2013-03-31 $-0.00B $0.00B -133.33%
2012-12-31 $-0.00B $0.01B -114.29%
2012-09-30 $-0.00B $0.00B -533.33%
2012-06-30 $-0.00B $0.00B -266.67%
2012-03-31 $-0.01B $0.00B -222.22%
2011-12-31 $-0.01B $0.00B -200.00%
2011-09-30 $-0.00B $0.00B -123.08%
2011-06-30 $-0.01B $0.00B -133.33%
2011-03-31 $-0.01B $0.00B -117.65%
2010-12-31 $-0.01B $0.00B -141.18%
2010-09-30 $-0.01B $0.01B -164.71%
2010-06-30 $-0.01B $0.01B -164.71%
2010-03-31 $-0.01B $0.00B -276.92%
2009-12-31 $-0.01B $0.00B -240.00%
2009-09-30 $-0.01B $0.01B -235.29%
2009-06-30 $-0.01B $0.00B -220.00%
2009-03-31 $-0.01B $0.00B -165.52%
2008-12-31 $-0.01B $0.01B -133.33%
2008-09-30 $-0.01B $0.01B -104.00%
2008-06-30 $-0.02B $0.01B -104.92%
2008-03-31 $-0.01B $0.01B -104.00%
2007-12-31 $-0.01B $0.02B -122.22%
2007-09-30 $-0.01B $0.02B -210.53%
2007-06-30 $-0.01B $0.00B inf%
2007-03-31 $-0.00B $0.00B inf%
2006-12-31 $-0.00B $0.00B inf%
2006-09-30 $-0.00B $0.00B inf%
2006-06-30 $0.00B $0.00B nan%
2006-03-31 $0.00B $0.00B nan%
2005-12-31 $0.00B $0.00B nan%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.115B $0.001B
Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $176.761B 33.20
Medtronic (MDT) Ireland $129.154B 20.98
Stryker (SYK) United States $70.955B 27.51
Boston Scientific (BSX) United States $51.986B 30.70
Lonza Group Ag (LZAGY) Switzerland $46.178B 0.00
Baxter (BAX) United States $41.045B 25.10
Terumo (TRUMY) Japan $29.530B 37.75
ResMed (RMD) United States $29.334B 46.29
EssilorLuxottica Societe Anonyme (ESLOY) France $28.492B 0.00
Zimmer Biomet Holdings (ZBH) United States $26.965B 22.45
Sunny Optical Technology (SNPTF) China $20.566B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.585B 0.00
Bio-Rad Laboratories (BIO) United States $15.620B 70.72
Insulet (PODD) United States $13.019B 1289.81
Quidel (QDEL) United States $12.525B 66.35
Shandong Weigao Medical Polymer (SHWGF) China $11.849B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
Perrigo (PRGO) Ireland $7.514B 13.44
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Canopy Growth (CGC) Canada $7.165B 0.00
Hill-Rom Holdings (HRC) United States $6.311B 15.66
GW Pharmaceuticals (GWPH) United Kingdom $4.203B 0.00
Neogen (NEOG) United States $4.135B 69.10
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.995B 0.00
Haemonetics (HAE) United States $3.842B 25.80
ICU Medical (ICUI) United States $3.834B 27.97
Envista Holdings (NVST) United States $3.641B 24.83
Abcam (ABCZY) $3.406B 0.00
Agios Pharmaceuticals (AGIO) United States $3.048B 0.00
NuVasive (NUVA) United States $2.754B 38.38
National Vision Holdings (EYE) United States $2.703B 46.76
TG Therapeutics (TGTX) United States $2.246B 0.00
AtriCure (ATRC) United States $1.854B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.706B 157.08
MacroGenics (MGNX) United States $1.438B 0.00
Aphria (APHA) Canada $1.408B 0.00
NanoString Technologies (NSTG) United States $1.349B 0.00
Aurora Cannabis (ACB) Canada $1.239B 0.00
Cerus (CERS) United States $1.225B 0.00
OraSure Technologies (OSUR) United States $1.197B 241.13
Vapotherm (VAPO) United States $1.124B 0.00
Meridian Bioscience (VIVO) United States $1.091B 41.06
Cardiovascular Systems (CSII) United States $1.086B 0.00
PetIQ (PETQ) United States $1.062B 30.68
InMode (INMD) Israel $1.053B 22.24
Owens & Minor (OMI) United States $1.047B 23.74
Phibro Animal Health (PAHC) United States $0.951B 18.96
Quanterix (QTRX) United States $0.934B 0.00
Omeros (OMER) United States $0.714B 0.00
BioLife Solutions (BLFS) United States $0.670B 190.82
Eagle Pharmaceuticals (EGRX) United States $0.659B 47.18
Surmodics (SRDX) United States $0.640B 77.15
VAREX IMAGING (VREX) United States $0.636B 15.80
Zynex (ZYXI) United States $0.626B 54.70
LeMaitre Vascular (LMAT) United States $0.595B 36.42
Lantheus Holdings (LNTH) United States $0.503B 11.72
Viemed Healthcare (VMD) United States $0.434B 38.48
Cytosorbents (CTSO) United States $0.341B 0.00
HEXO (HEXO) $0.338B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.331B 0.00
Utah Medical Products (UTMD) United States $0.295B 25.33
InfuSystems Holdings (INFU) United States $0.256B 141.56
Organigram Holdings (OGI) Canada $0.228B 0.00
Female Health (VERU) United States $0.214B 0.00
Chimerix (CMRX) United States $0.207B 0.00
Exagen (XGN) United States $0.177B 0.00
Bovie Medical (APYX) United States $0.168B 0.00
Fonar (FONR) United States $0.161B 14.24
Surface Oncology (SURF) United States $0.159B 0.00
Wound Management Technologies (SMTI) United States $0.149B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.126B 0.00
Rockwell Medical (RMTI) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.119B 0.00
Evolus (EOLS) United States $0.106B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
MTech Acquisition (KERN) United States $0.089B 0.00
Nephros (NEPH) United States $0.076B 0.00
United-Guardian (UG) United States $0.072B 16.78
Brainsway (BWAY) Israel $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.059B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.034B 0.00
Akers Biosciences Inc (AKER) United States $0.031B 0.00
FSD PHARMA INC (HUGE) Canada $0.028B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00